Lawrence J. Lesko

Pharmacokinetic analysis of bioequivalence trials: Implications for sex‐related issues in clinical pharmacology and biopharmaceutics

Donald J. Schuirmann, L. Lesko, R. Williams, 2000, Clinical pharmacology and therapeutics.

Application of a patient‐centered reverse translational systems‐based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2022, Clinical and translational science.

Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2022, CPT: pharmacometrics & systems pharmacology.

Use of biomarkers from drug discovery through clinical practice: Report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development

L. Lesko, A. Atkinson, P. Rolan, 2003, Clinical pharmacology and therapeutics.

Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions

Yaning Wang, Justin C. Earp, Christoffer Tornoe, 2011, Clinical pharmacokinetics.

Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study

B. McCrindle, L. Lesko, A. Michelson, 2021, Journal of clinical pharmacology.

Development of in vivo bioequivalence methodology for dermatologic corticosteroids based on pharmacodynamic modeling

L. Lesko, V. Shah, R. Williams, 1999, Clinical pharmacology and therapeutics.